MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
33.28
+1.32 (4.13%)
At close: Jun 26, 2026, 4:00 PM EDT
32.61
-0.67 (-2.01%)
After-hours: Jun 26, 2026, 5:02 PM EDT
MapLight Therapeutics Market Cap
MapLight Therapeutics has a market cap or net worth of $1.51 billion as of June 26, 2026.
Market Cap
1.51B
Enterprise Value
1.20B
1-Year Change
n/a
Ranking
Category
Stock Price
$33.28
Market Cap Chart
Since the IPO on October 27, 2025, MapLight Therapeutics's market cap has increased from $704.29M to $1.51B, an increase of 114.27%. That is a compound annual growth rate of 215.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 1.51B | 96.87% |
| Dec 31, 2025 | 766.56M | 8.84% |
| Oct 27, 2025 | 704.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Maravai LifeSciences Holdings | 1.61B |
| ArriVent BioPharma | 1.58B |
| Maze Therapeutics | 1.57B |
| Immunocore Holdings | 1.57B |
| Damora Therapeutics | 1.56B |
| Capricor Therapeutics | 1.53B |
| Hemab Therapeutics Holdings | 1.51B |
| Savara | 1.50B |